Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Rebecca Berhanu"'
Publikováno v:
BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Multi-drug resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in pregnant women is a cause for concern globally; few data have described the safety of second-line anti-TB medications during pregnancy. We aim to describe T
Externí odkaz:
https://doaj.org/article/c00c7c56d95d4604a4834dc3d07a10ad
Autor:
Lise Jamieson, Denise Evans, Rebecca Berhanu, Nazir Ismail, Samantha Aucock, Kristina Wallengren, Lawrence Long
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background To assess the quality and completeness of treatment and outcome data in the electronic tuberculosis (TB) and antiretroviral treatment (ART) registers in drug-resistant (DR-) TB patients at three treatment facilities in South Afric
Externí odkaz:
https://doaj.org/article/99b67648338c4cf09ab8e58f368f54f1
Autor:
Tembeka Sineke, Denise Evans, Kathryn Schnippel, Heleen van Aswegen, Rebecca Berhanu, Nozipho Musakwa, Elisabet Lönnmark, Lawrence Long, Sydney Rosen
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-15 (2019)
Abstract Background Adverse events (AEs) are common during treatment of drug-resistant tuberculosis (DR-TB). Little is known about the health-related quality of life (HRQoL) of patients receiving treatment for DR-TB or the effect of AEs on HRQoL. Met
Externí odkaz:
https://doaj.org/article/6fbd5de374b345aeb59b81fb364e58a9
Autor:
Denise Evans, Tembeka Sineke, Kathryn Schnippel, Rebecca Berhanu, Caroline Govathson, Andrew Black, Lawrence Long, Sydney Rosen
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In 2011, South Africa improved its ability to test for rifampicin-resistant TB (RR-TB) by introducing GeneXpert MTB/RIF. At the same time, the South African National TB program adopted a policy decentralized, outpatient treatment
Externí odkaz:
https://doaj.org/article/62ecf07303d645eaa66a1fad86448d76
Autor:
Denise Evans, Kamban Hirasen, Rebecca Berhanu, Given Malete, Prudence Ive, David Spencer, Sharlaa Badal-Faesen, Ian M. Sanne, Matthew P. Fox
Publikováno v:
AIDS Research and Therapy, Vol 15, Iss 1, Pp 1-12 (2018)
Abstract Background While efficacy data exist, there are limited data on the outcomes of patients on third-line antiretroviral therapy (ART) in sub-Saharan Africa in actual practice. Being able to identify predictors of switch to third-line ART will
Externí odkaz:
https://doaj.org/article/6a7a2ff2cee94eae8418f7284dbf4351
Autor:
Craig van Rensburg, Rebecca Berhanu, Kamban Hirasen, Denise Evans, Sydney Rosen, Lawrence Long
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217820 (2019)
BackgroundDrug resistant-tuberculosis is a growing burden on the South African health care budget. In response the National Department of Health implemented two important strategies in 2011; universal access to drug-sensitivity testing for rifampicin
Externí odkaz:
https://doaj.org/article/aef12d0a613a47349046f80c7c981081
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205463 (2018)
INTRODUCTION:Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43-48%, falling short of the World Health Organization's target of ≥75%. We present rates and assess predictor
Externí odkaz:
https://doaj.org/article/a77b5a62888340ea9fdadd28ffe6d0e5
Autor:
Kathryn Schnippel, Kate Shearer, Denise Evans, Rebecca Berhanu, S’celo Dlamini, Norbert Ndjeka
Publikováno v:
International Journal of Infectious Diseases, Vol 39, Iss C, Pp 89-94 (2015)
Background: The South African Electronic Drug-Resistant Tuberculosis Register (EDRweb) is the national database of registered drug-resistant tuberculosis (DR-TB) cases. Methods: This study was a retrospective, de-identified secondary analysis of EDRw
Externí odkaz:
https://doaj.org/article/7debe1c5042146209740007718810534
Autor:
Denise Evans, Kathryn Schnippel, Caroline Govathson, Tembeka Sineke, Andrew Black, Lawrence Long, Rebecca Berhanu, Sydney Rosen
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181238 (2017)
In South Africa, roughly half of the drug-resistant TB cases diagnosed are reported to have been started on treatment. We determined the proportion of persons diagnosed with rifampicin resistant (RR-) TB who initiated treatment in Johannesburg after
Externí odkaz:
https://doaj.org/article/2938fcd40c8545f88bd19e9a4e1a0468
Autor:
Julia K Rohr, Prudence Ive, C Robert Horsburgh, Rebecca Berhanu, Kate Shearer, Mhairi Maskew, Lawrence Long, Ian Sanne, Jean Bassett, Osman Ebrahim, Matthew P Fox
Publikováno v:
Journal of the International AIDS Society, Vol 19, Iss 1, Pp n/a-n/a (2016)
Introduction A substantial number of patients with HIV in South Africa have failed first‐line antiretroviral therapy (ART). Although individual predictors of first‐line ART failure have been identified, few studies in resource‐limited settings
Externí odkaz:
https://doaj.org/article/050d9b4cd0c84d36adbd4a9a8e4759b3